Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Law

Showing results (251-260 of 278) with videos related to

Pageof 28
Sort By:
BMJ Open|April 16, 2024
Multicentre double-blind randomised placebo-controlled trial evaluating the efficacy of the meningococcal B vaccine, 4CMenB (Bexsero), against <i>Neisseria gonorrhoeae</i> infection in men who have sex with men: the GoGoVax study protocolKate L Seib, Basil Donovan, Caroline Thng, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 3, 2026
Regional variations of rates and determinants of drug resistance mutations in people failing first-line therapy for HIV-1: a substudy from the D2EFT phase 3b/4 clinical trialBillal Musah Obeng, Jolie Hutchinson, Ansari Shaik, et al.
Antiviral Therapy|March 6, 2019
Cardiovascular disease incidence projections in the TREAT Asia HIV Observational Database (TAHOD)Rimke Bijker, Nagalingeswaran Kumarasamy, Sasisopin Kiertiburanakul, et al.
HIV Research & Clinical Practice|August 8, 2022
Adaption of an ongoing clinical trial to quickly respond to gaps in changing international recommendations: the experience of D<sup>2</sup>EFTEmmanuelle Papot, Simone Jacoby, Dona Arlinda, et al.
The Lancet Regional Health. Western Pacific|October 21, 2021
The longer-term effects of access to HIV self-tests on HIV testing frequency in high-risk gay and bisexual men: follow-up data from a randomised controlled trialYe Zhang, Muhammad S Jamil, Kirsty S Smith, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 9, 2015
Implementation and Operational Research: Effects of CD4 Monitoring Frequency on Clinical End Points in Clinically Stable HIV-Infected Patients With Viral SuppressionJin Young Ahn, David Boettiger, Matthew Law, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 23, 2013
Intensity of human prion disease surveillance predicts observed disease incidenceGenevieve M J A Klug, Handan Wand, Marion Simpson, et al.
The Lancet. Global Health|October 15, 2019
Strategies to improve control of sexually transmissible infections in remote Australian Aboriginal communities: a stepped-wedge, cluster-randomised trialJames Ward, Rebecca J Guy, Alice R Rumbold, et al.
The New England Journal of Medicine|June 23, 2021
Azithromycin or Doxycycline for Asymptomatic Rectal <i>Chlamydia trachomatis</i>Andrew Lau, Fabian Y S Kong, Christopher K Fairley, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 13, 2023
Measures of Longitudinal Immune Dysfunction and Risk of AIDS and Non-AIDS Defining Malignancies in Antiretroviral-Treated People With Human Immunodeficiency VirusFrédérique Chammartin, Amanda Mocroft, Alexander Egle, et al.
Pageof 28

Showing results (251-260 of 278) with videos related to

Sort By:
Pageof 28
BMJ Open|April 16, 2024
Multicentre double-blind randomised placebo-controlled trial evaluating the efficacy of the meningococcal B vaccine, 4CMenB (Bexsero), against <i>Neisseria gonorrhoeae</i> infection in men who have sex with men: the GoGoVax study protocolKate L Seib, Basil Donovan, Caroline Thng, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 3, 2026
Regional variations of rates and determinants of drug resistance mutations in people failing first-line therapy for HIV-1: a substudy from the D2EFT phase 3b/4 clinical trialBillal Musah Obeng, Jolie Hutchinson, Ansari Shaik, et al.
Antiviral Therapy|March 6, 2019
Cardiovascular disease incidence projections in the TREAT Asia HIV Observational Database (TAHOD)Rimke Bijker, Nagalingeswaran Kumarasamy, Sasisopin Kiertiburanakul, et al.
HIV Research & Clinical Practice|August 8, 2022
Adaption of an ongoing clinical trial to quickly respond to gaps in changing international recommendations: the experience of D<sup>2</sup>EFTEmmanuelle Papot, Simone Jacoby, Dona Arlinda, et al.
The Lancet Regional Health. Western Pacific|October 21, 2021
The longer-term effects of access to HIV self-tests on HIV testing frequency in high-risk gay and bisexual men: follow-up data from a randomised controlled trialYe Zhang, Muhammad S Jamil, Kirsty S Smith, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 9, 2015
Implementation and Operational Research: Effects of CD4 Monitoring Frequency on Clinical End Points in Clinically Stable HIV-Infected Patients With Viral SuppressionJin Young Ahn, David Boettiger, Matthew Law, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 23, 2013
Intensity of human prion disease surveillance predicts observed disease incidenceGenevieve M J A Klug, Handan Wand, Marion Simpson, et al.
The Lancet. Global Health|October 15, 2019
Strategies to improve control of sexually transmissible infections in remote Australian Aboriginal communities: a stepped-wedge, cluster-randomised trialJames Ward, Rebecca J Guy, Alice R Rumbold, et al.
The New England Journal of Medicine|June 23, 2021
Azithromycin or Doxycycline for Asymptomatic Rectal <i>Chlamydia trachomatis</i>Andrew Lau, Fabian Y S Kong, Christopher K Fairley, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 13, 2023
Measures of Longitudinal Immune Dysfunction and Risk of AIDS and Non-AIDS Defining Malignancies in Antiretroviral-Treated People With Human Immunodeficiency VirusFrédérique Chammartin, Amanda Mocroft, Alexander Egle, et al.
Pageof 28